Socio-cultural determinants of anticipated acceptance of an oral cholera vaccine in Western Kenya.

Epidemiology and Infection
Neisha SundaramMitchell G Weiss

Abstract

Determinants of anticipated acceptance of an oral cholera vaccine (OCV) were studied in urban and rural communities of Western Kenya. An explanatory model interview administered to 379 community residents assessed anticipated vaccine acceptance at various prices from no cost to full-cost recovery, socio-cultural features of cholera and social characteristics. Nearly all (99%) residents indicated willingness to accept a no-cost OCV, 95% at a price of US$ 0·8, 73% at US$ 4·2 and 59% at US$ 8·4. Logistic regression models analysed socio-cultural determinants of anticipated OCV acceptance. Prominence of non-specific symptoms for cholera was negatively associated with acceptance. A cholera-specific symptom (thirst), self-help referring to prayer, income and education were positively associated. In the high-cost model, education was no longer significant and reliance on herbal treatment was a significant determinant of vaccine non-acceptance. Findings suggest high motivation for OCVs, if affordable. Socio-cultural determinants are better predictors of anticipated acceptance than socio-demographic factors alone.

References

Sep 1, 1996·Social Science & Medicine·M K Nations, C M Monte
Aug 4, 1999·The American Journal of Tropical Medicine and Hygiene·C Weijer
Jun 6, 2003·Journal of Ethnopharmacology·Esther N Matu, Johannes van Staden
Jun 5, 2004·Journal of Molecular Graphics & Modelling·Xin HuWilliam H Shelver
Feb 25, 2005·The New England Journal of Medicine·Marcelino E S LucasJohn D Clemens
Aug 31, 2006·Health Policy and Planning·J A CassellC H Mercer
Jan 30, 2007·Vaccine·Marcelino E S LucasDale Whittington
Mar 29, 2007·PLoS Medicine·Ayodele Samuel Jegede
Jun 23, 2007·The Lancet Infectious Diseases·Jane N ZuckermanAlain Fisch
Sep 8, 2007·Health Policy·Ziaul IslamDale Whittington
Feb 2, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Dohyeong KimDale Whittington
Oct 17, 2008·Journal of Biosocial Science·Gebremariam Woldemicael
Jan 17, 2009·Health Policy and Planning·Inge PetersenUNKNOWN Mental Health and Poverty Research Programme Consortium
Oct 16, 2009·BMC International Health and Human Rights·Léonard FournRoméo Gansey
Oct 16, 2009·BMC International Health and Human Rights·Steven MitchellAnne Cockcroft
Dec 10, 2009·The American Journal of Tropical Medicine and Hygiene·O-Tipo ShikangaDaniel R Feikin
Apr 24, 2010·Journal of Health, Population, and Nutrition·K Zaman
May 21, 2010·Vaccine·UNKNOWN WHO Publication
Aug 5, 2010·The American Journal of Tropical Medicine and Hygiene·Daniel R FeikinJohn Gichuki
Oct 15, 2010·Journal of Health, Population, and Nutrition·Mohammad AliJohn D Clemens
Nov 30, 2010·BMC Infectious Diseases·Christian SchaettiMitchell G Weiss
Feb 16, 2011·BMC Public Health·Wilhelmina L M RuijsMarlies E J L Hulscher
Jun 15, 2011·Lancet·Heidi J LarsonScott Ratzan
Jan 10, 2012·Advances in Preventive Medicine·Sharon Teitler-RegevUri Benzion

❮ Previous
Next ❯

Citations

Sep 21, 2013·BMC Medicine·Christian SchaettiMitchell G Weiss
Jun 26, 2015·Human Vaccines & Immunotherapeutics·Neisha SundaramMitchell G Weiss
Dec 9, 2014·Human Vaccines & Immunotherapeutics·Shantanu K KarLinda M Kaljee

❮ Previous
Next ❯

Software Mentioned

Epi Info
Explanatory Model Interview Catalogue ( EMIC )
MAXQDA
SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.